These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16807138)

  • 61. Increased mutant frequencies in the HPRT gene locus of leukemia HL-60 cells treated with succinylacetone.
    Zheng KC; Yalowich JC; Kagan VE; Keohavong P
    Cell Biol Toxicol; 2006 Sep; 22(5):361-70. PubMed ID: 16838078
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Leukemia and lymphoma: a cost of doing business for adaptive immunity.
    Schlissel MS; Kaffer CR; Curry JD
    Genes Dev; 2006 Jun; 20(12):1539-44. PubMed ID: 16778072
    [No Abstract]   [Full Text] [Related]  

  • 63. Uncovering the V(D)J recombinase.
    Schatz DG; Baltimore D
    Cell; 2004 Jan; 116(2 Suppl):S103-6, 2 p following S106. PubMed ID: 15055595
    [No Abstract]   [Full Text] [Related]  

  • 64. V(D)J recombination causes dangerous chromosome liaisons in developing thymocytes.
    Yin B; Bassing CH
    Cell Cycle; 2009 Aug; 8(16):2486-7. PubMed ID: 19684464
    [No Abstract]   [Full Text] [Related]  

  • 65. Leukemic transformation.
    Lin YW; Aplan PD
    Cancer Biol Ther; 2004 Jan; 3(1):13-20. PubMed ID: 14726677
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Forward genetic screen of human transposase genomic rearrangements.
    Henssen AG; Jiang E; Zhuang J; Pinello L; Socci ND; Koche R; Gonen M; Villasante CM; Armstrong SA; Bauer DE; Weng Z; Kentsis A
    BMC Genomics; 2016 Aug; 17():548. PubMed ID: 27491780
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.
    Larmonie NS; Dik WA; Meijerink JP; Homminga I; van Dongen JJ; Langerak AW
    Haematologica; 2013 Aug; 98(8):1173-84. PubMed ID: 23904235
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial.
    McGann PT; Flanagan JM; Howard TA; Dertinger SD; He J; Kulharya AS; Thompson BW; Ware RE;
    Pediatr Blood Cancer; 2012 Aug; 59(2):254-7. PubMed ID: 22012708
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
    Fenstermaker RA; Ciesielski MJ
    Curr Genomics; 2007 May; 8(3):163-70. PubMed ID: 18645600
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Accessibility control of V(D)J recombination.
    Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
    Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model.
    Tycko B; Sklar J
    Cancer Cells; 1990 Jan; 2(1):1-8. PubMed ID: 2201335
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
    Finette BA
    DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
    [TBL] [Abstract][Full Text] [Related]  

  • 73. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
    Finette BA; Poseno T; Albertini RJ
    Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
    Messier TL; O'Neill JP; Finette BA
    Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.
    Yoshioka M; O'Neill JP; Vacek PM; Finette BA
    Cancer Res; 2001 Apr; 61(8):3432-8. PubMed ID: 11309304
    [TBL] [Abstract][Full Text] [Related]  

  • 76. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.
    Fuscoe JC; Zimmerman LJ; Lippert MJ; Nicklas JA; O'Neill JP; Albertini RJ
    Cancer Res; 1991 Nov; 51(21):6001-5. PubMed ID: 1933863
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.